Crossmark

Combination of apolipoprotein-A-I/apolipoprotein-A-I binding protein and anti-VEGF treatment overcomes anti-VEGF resistance in choroidal neovascularization in mice

Crossref DOI link: https://doi.org/10.1038/s42003-020-1113-z

Published Online: 2020-07-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhu, Lingping

Parker, Mackenzie https://orcid.org/0000-0001-7010-4620
Enemchukwu, Nduka

Shen, Megan

Zhang, Guogang

Yan, Qing

Handa, James T.

Fang, Longhou https://orcid.org/0000-0003-1653-5221
Fu, Yingbin
Funding

Funding for this research was provided by:

U.S. Department of Health & Human Services | NIH | National Eye Institute (2P30EY002520)

BrightFocus Foundation
License Information

Text and Data Mining valid from 2020-07-16

Version of Record valid from 2020-07-16
More Information

Article History

Received: 29 November 2019

Accepted: 29 June 2020

First Online: 16 July 2020

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below